GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » Additional Paid-In Capital

Lobe Sciences (XCNQ:LOBE) Additional Paid-In Capital : C$0.00 Mil(As of Feb. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences Additional Paid-In Capital?


Lobe Sciences's annual additional paid-in capital declined from Aug. 2022 (C$1.30 Mil) to Aug. 2023 (C$0.00 Mil) but then stayed the same from Aug. 2023 (C$0.00 Mil) to Aug. 2024 (C$0.00 Mil).


Lobe Sciences Additional Paid-In Capital Historical Data

The historical data trend for Lobe Sciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Additional Paid-In Capital Chart

Lobe Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.25 1.30 - -

Lobe Sciences Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.09 3.09 - - -

Lobe Sciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Lobe Sciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences Business Description

Traded in Other Exchanges
Address
1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines